Federal funding cuts in health care will jeopardize patient outcomes and ultimately raise costs
As Trump and Congress debate the Big Beautiful Bill, public health, medical research, and Medicaid could ‘Make America Healthy Again’ — if the nation pays for them.
Medtronic to spin off diabetes unit into standalone company
Medtronic announces a diabetes business spinoff to enhance focus on growth areas, aiming for improved financial performance and shareholder value.
ReGelTec’s HYDRAFIL System receives CE Mark for treating chronic low back pain
ReGelTec's HYDRAFIL System offers a minimally invasive treatment for chronic low back pain, promising significant pain relief and improved function.
Former President Joe Biden’s cancer diagnosis: What we know so far, and treatment options
Biden reveals aggressive prostate cancer that has metastasized to his bones.
Trump, HHS take aim at drug prices with policies affecting Big Pharma, ending ‘global free-riding’
HHS announces plan to create ‘most-favored-nation’ cost scale so U.S. is not subsidizing drug prices in other countries.
Choosing the best EHR platform for your practice: 10 essential tips
Avoid regret: 10 things every physician should know before choosing an electronic health record (EHR) platform.
Compounded GLP-1 RA drugs: Getting to know about pharmacy compounding
APC CEO Scott Brunner, CAE, discusses compounding drugs, including the GLP-1 RA antidiabetes and antiobesity medications.
Compounded GLP-1 RA drugs: Advice to physicians and other prescribers
Compounded GLP-1 RA drugs: What about prices? Are compounded drugs cheaper or more expensive than manufacturers’ versions?
Primary care on the front lines of the youth mental health crisis
A new national report finds primary care physicians diagnose 41% of pediatric major depressive disorder cases, often before crisis hits.
Doctors are drowning in paperwork. Remote talent may be the lifeline
Remote support is helping primary care practices reduce administrative stress, allowing physicians to focus more on patient care.
It’s time to bring value-based care principles to hospice
How do hospice services for end of life align with value-based care? Here’s what primary care physicians should know.
Atia Vision receives FDA approval to begin clinical trial of novel intraocular lens
Atia Vision's OmniVu lens system promises a breakthrough in cataract surgery with enhanced vision restoration.
Biden prostate cancer diagnosis: A physician expert offers his first impressions
The former president likely will have drug therapy to lower his testosterone levels, but there are other treatment options.
Compounded GLP-1 RA drugs: Can pharmacists make drugs that are essentially a copy of another drug? Part 2
World’s first human bladder transplant performed at UCLA; a potential opioid alternative without the downsides; more time spent sitting heightens risk after a cardiac event – Morning Medical Update
The top news stories in medicine today.
The good news on vaccines: Innovation is flourishing
An expert physician panel discusses how vaccine policy has gone wrong under the Trump administration, why misinformation has flourished and what individual physicians can do to win back patient trust.
Biden prostate cancer diagnosis: The newest developments for doctors
Daniel Isaac, DO, MS, an oncologist/hematologist, discusses the publicly disclosed diagnosis of prostate cancer in former President Joe Biden.
Biden prostate cancer diagnosis: The importance of primary care and cancer detection
Biden prostate cancer diagnosis: Surgerical options, and discovering the disease
Biden prostate cancer diagnosis: Treatment options
Biden prostate cancer diagnosis: What we know so far
Compounded GLP-1 RA drugs: GLP-1 RA drugs are no longer in shortage, but compounding customized versions of them may continue, part 1
Compounded GLP-1 RA drugs: A continuing discussion about GLP-1 RA drugs, the perfect storm of demand and shortages, part 2
What you don’t know about annuities can hurt you
Lack of awareness leads many to overlook these potent financial tools
In Medicare Advantage value-based care, women PCPs outperform and outearn their male peers
A new study in JAMA Health Forum finds women primary care physicians earn more under value-based models — while delivering better outcomes and fewer hospital visits.
Compounded GLP-1 RA drugs: Are GLP-1 RA drugs the biggest phenomenon in American health care? Part 1
US tariffs threaten growth plans for European medtech firms, study finds
U.S. tariffs are disrupting European medtech growth, forcing firms to adapt supply chains and prioritize cost optimization amid rising challenges and uncertainties.
Compounded GLP-1 RA drugs: Criteria for compounding medicines to fill gaps that drugmakers can’t fill
Compounded GLP-1 RA drugs: An introduction to the Alliance for Pharmacy Compounding
